Kathryn Junne Samson

Caring Nurse with 15 years of experience in diverse healthcare organization working clinical research patients. Adept at introducing detailed care plans and coordinating patient care through interdisciplinary collaboration. Demonstrated expertise in physical, psychosocial, developmental and educational aspects of nursing care for clinical research patients and families.

• Obtain patient’s vital signs and weight.
• Conducts pulmonary function test to subjects per visit.
• Dispense investigational products to patients.
• Other duties as assigned
• Implements data collection, coordinate the collection and analysis of research data.
• Instructs and coordinates research subjects as suitable to specific study objectives and work scope.
• Able to operate PFT machine and Electronic diary.
• Do Pulmonary Function Tests and ECG to research subjects per visit.
• Instructs study subjects in using E-diary and administering study drugs.
• Ensures the smooth and efficient day-to-day operation of research and data collection activities.
• Coordinates the day-to-day activities of any technical support staff specifically engaged in the carrying out of research/clinical protocol.
• Implement quality control process throughout the conduct of the trial.
• Observe confidentiality and safeguards all patient related information.
• Perform miscellaneous job-related duties as assigned.

• Dr. Joel M. Santiagel, Quirino Memorial Medical Center, Genentech GB44332 A Phase III, Randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of Astegolimab in patients with chronic obstructive pulmonary disease, Nurse- Study Coordinator, 10/23/2023, present
• Seqirus A Phase I, Randomized, Observer-Blind, Multi-Center, Dose Ranging Study to evaluate the immunogenicity, safety and tolerability of different formulations of an adjuvanted cell culture-derived A/H2N3 sub-unit influenza virus vaccine in healthy subjects 18 years and above (V204), Unblinded Nurse- Study Coordinator, 08/31/2023, present
• Wantai A Multi-center, randomized, double-blinded, placebo-controlled phase 3 Clinical Trial of Influenza Virus Vector COVID-19 Vaccine for Intranasal Spray (DelNS1-2019-nCoV-RBD-OPT1) in healthy participants of 18 Years and Older (COVID-19-PRO-003), Nurse- Study Coordinator, 01/06/2022, present
• Vicore A randomized, double-blind, placebo-controlled, parallel group, phase 3, multicenter trial investigating the efficacy and safety of C21 as add on to standard of care in adult subjects with COVID-19 (ATTRACT-3), Nurse- Study Coordinator, 12/14/2021, 09/2022
• Vaccines in the Philippines: Randomized Trial of Candidate Vaccines for COVID-19 (STV), Nurse- Study Coordinator, 10/05/2021, 12/2021
• Biokangtai A multi-national, randomized, double-blind, placebo-controlled phase III clinical study to evaluate the efficacy, safety and immunogenicity of SARS-COV-2 Vaccine (Vero cells), Inactivated for the prevention of COVID-19 in healthy adults aged 18 years and older., Nurse- Study Coordinator, 08/25/2021, present
• WestVac A global multicenter, randomized, double-blind, placebo-controlled, phase III clinical trial to evaluate the efficacy, safety and immunogenicity of recombinant COVID-19 vaccine (sf9 cells), for the prevention of COVID-19 in adults aged 18 years and older. WestVac Bippharma Co.,Ltd and West China Hospital at Sichuan University, Nurse- Study Coordinator, 07/30/2021, present
• Dr. Lalaine L. Mortera, MCU-FDTMF Hospital, Shionogi Phase 3, A Multicenter, Randomized, Double-blind, Parallel-group, Clinical Study of S 649266 Compared with Meropenem for the Treatment of Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia, or Healthcare-associated Bacterial Pneumonia Caused by Gram negative Pathogens, Nurse- Study Coordinator, 09/2017, 04/2019
• Nabriva A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC3781) Versus Oral Moxifloxacin in Adults with Community-Acquired Bacterial Pneumonia, Nurse- Study Coordinator, 12/2016, 06/2018
• Chiltern Phase 2/3 randomized, open label, multi-center study to determine safety and efficacy of Solithromycin in Adolescents (2months to 17y/o) with suspected or confirmed CABP, Nurse- Study Coordinator, 12/2016, 04/2018
• Paratek A Phase 3, Randomized, Double-Blind, Multi-center Study to compare Safety and Efficacy of Omadacycline IV/PO to Moxifloxacin IV/PO for treating adult subjects with Community-Acquired Bacterial Pneumonia (CABP), Nurse- Study Coordinator, 10/2016, 04/2017
• Avant A 24 Week dummy, multicentre study to assess the efficacy and safety of aclidinium bromide/ formoterol fumarate compared with individual components and placebo and aclidinium bromide compared with placebo when administered to patients with stable chronic obstructive pulmonary disease, Nurse- Study Coordinator, 04/2016, 04/2019
• Vectura A randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy of two doses of nebulized budesonide delivered by the VR475 Inhalation System, with an open-label comparison to conventionally nebulized budesonide, in patients with uncontrolled asthma despite treatment with high dose inhaled corticosteroid and at least a second controller (GINA Step 4) and those receiving oral corticosteroid (GINA Step 5) – VR475/3/001), Nurse- Study Coordinator, 01/2016, 04/2019
• Impact A phase III, 52 week, randomized, double-blind, 3-arm parallel group study, comparing the efficacy, safety and tolerability of the fixed dose triple combination FF/UMEC/VI with the fixed dose dual combinations of FF/VI and UMEC/VI, all administered once-daily in the morning via a dry powder inhaler in subjects with chronic obstructive pulmonary disease (IMPACT Study), Nurse- Study Coordinator, 05/2016, 08/2017
• Astrazeneca A 52-week, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents with Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting B2-Agonist (STRATOS 2), Nurse- Study Coordinator, 11/2015, 02/2018
• Cubist Pharmaceuticals Inc. CXA-NP-11-04 A prospective, randomized, double-blind, multicenter, Phase 3 study to assess the safety and efficacy of intravenous Ceftolozane/Tazobactam compared with Meropenem in compared adult patients with Ventilated Nosocomial Pneumonia (VNP), Nurse- Study Coordinator, 08/2015, 06/2018
• Cempra Pharmaceuticals Inc. CEO1-301 A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia, Nurse- Study Coordinator, 01/2015, 10/2015
• GlaxoSmith Kline HZC1137832 A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or at increased risk for cardiovascular disease, Nurse- Study Coordinator, 02/2012, 05/2015
• Boehringer-Ingelheim 352.2046 A randomized, double-blind, active-controlled study to evaluate the impact of stepwise withdrawal of inhaled corticosteroid treatment in patients with severe to very severe chronic obstructive pulmonary disease (COPD) on optimized bronchodilator therapy, Nurse- Study Coordinator, 12/2009, 12/2013

• The Medical City, Victory Mall, Caloocan City, Medical Secretary, Dr. Edna C. Banta (Obstetrician –Oncologist), 01/2010, 08/2010
• One World Medical Wellness Center, D.Macapagal Boulevard, Pasay City, Swab Nurse Customer Service Representative, 04/2021, 08/2022

• ARNASA (GB44332) Investigator Meeting, InterContinental Singapore, 08/23/2023
• Good Clinical Practice (GCP) –NIDA Clinical Trials Network –online training, 08/22/2023
• Mayo Medical Laboratories- IATA Certification for transporting dangerous goods, 12/2021
• Good Clinical Practice (GCP) –NIDA Clinical Trials Network –online training, 06/27/2021
• Good Clinical Practice (GCP) workshop and training, Philippine Clinical Research Professionals Inc. – NIH Manila, 04/2018
• Avant, investigator’s meeting, Hilton Hotel Singapore, 01/2017
• Nabriva, investigator’s meeting, Corinthia Hotel Prague, 11/2016
• Paratek, investigator’s meeting, Corinthia Hotel Prague, 09/2016
• Mayo Medical Laboratories- IATA Certification for transporting dangerous goods, 07/2015
• IMPACT CTT116855 – Investigators Meeting, Holiday Inn, Makati, Phillipines, 11/2015
• Good Clinical Practice (GCP) –NIDA Clinical Trials Network –online training, 12/01/2014
• Cempra Pharmaceuticals Solitaire-IV Investigator’s Meeting, Sheraton Hsinchu Hotel, Taiwan, 06/2014
• Good Clinical Practice (GCP) workshop and training, Philippine Clinical Research Professionals Inc. – MCU-FDTMF Hospital, Caloocan City, 11/28/2012
• Good Clinical Practice (GCP) training for study coordinators, Union Bank Plaza, Meralco Ave. Pasig City, 09/21/2012
• Sputum Induction and Processing Training, Lung Center of the Philippines, 01/23/2012
• GlaxosmithKline, HZC113782 SUMMIT, investigator’s meeting, Swissotel Nai Lert Park, Bangkok, Thailand, 07/2011
• ICH GCP Training Workshop, Philippine Clinical Research Professionals, Inc. - MCU FDTMF Hospital Caloocan City, 12/07/2010
• Good Clinical Practice (GCP), CITI Collaborative Institutional Training Initiative, 10/20/2010
• Spirometry Training, Philippine General Hospital Pulmonary Laboratory, Outpatient Department, 05/2010